<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PR &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pr/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Oct 2026 21:17:31 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>PR &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Cost and Testing Access Limit Biomarker-Guided Breast Cancer Care in Benghazi, Oncologists Report</title>
		<link>https://bioengineer.org/cost-and-testing-access-limit-biomarker-guided-breast-cancer-care-in-benghazi-oncologists-report/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 23 Oct 2026 21:17:31 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Benghazi]]></category>
		<category><![CDATA[biomarker testing]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cross-sectional survey]]></category>
		<category><![CDATA[ER]]></category>
		<category><![CDATA[exploratory]]></category>
		<category><![CDATA[health care access]]></category>
		<category><![CDATA[HER2]]></category>
		<category><![CDATA[Ki-67]]></category>
		<category><![CDATA[Libya]]></category>
		<category><![CDATA[medical oncologists]]></category>
		<category><![CDATA[PR]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=450374</guid>

					<description><![CDATA[A survey of 27 medical oncologists in Benghazi found that most rate biomarker testing as extremely important for breast cancer treatment decisions, but high cost and limited testing centres are the leading reported barriers.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">450374</post-id>	</item>
	</channel>
</rss>
